BI 1815368, a potential oral treatment to improve vision in patients with diabetic macular edema, is being investigated in a ...

Treatment with botulinum toxin A appears to improve tear production and stability and relieve symptoms in patients with dry ...

Shares of Krystal Biotech KRYS gained 3.9% yesterday after the company announced that it had dosed the first patient in a ...

NEW HAVEN, Conn. (WTNH) – In this episode of CT BUZZ, Reporter Jillian Andrews sat down with Dr. Donald Higgins, Optometrist and Medical Director of the Dry Eye Treatment Center of Connecticut ...

Beacon's rare eye disease gene therapy signals vision function improvements in early phase 2 data By Zoey Becker May 7, 2025 7:15am Beacon Therapeutics gene therapy eye disease Retinitis Pigmentosa ...

A Johnson & Johnson gene therapy in development for an inherited vision-loss disorder has failed a Phase 3 study, the latest clinical research setback for a rare eye disease that so far has no FDA ...

The FDA last week approved (PDF) Neurotech’s cell therapy implant revakinagene taroretcel to treat the vision-robbing neurodegenerative disease macular telangiectasia (MacTel) type 2.

The FDA has approved a new gene therapy for macular telangiectasia type 2 (MacTel), a rare eye disease that causes vision loss.

Share on Pinterest An experimental stem cell therapy could help reverse corneal damage in people with a vision-threatening eye condition. Image credit: daliloveart/Getty Images. Researchers ...

A new therapy repairs corneal damage to a patient's eye using stem cells from their other, healthy eye.

Scientists in the UK have successfully used gene therapy to restore some vision to legally blind children with an inherited retinal condition. All 11 children in the clinical trial saw ...

Revolutionary gene therapy approaches show promise in treating various retinal conditions, potentially transforming treatment options for patients facing vision loss worldwide.